4.7 Article

MADS plus : discovery of differential splicing events from Affymetrix exon junction array data

期刊

BIOINFORMATICS
卷 26, 期 2, 页码 268-269

出版社

OXFORD UNIV PRESS
DOI: 10.1093/bioinformatics/btp643

关键词

-

资金

  1. National Institutes of Health [R01-HG004634, R01-GM088809, R01-CA093769]
  2. Edward Mallinckrodt, Jr. Foundation
  3. University of Iowa Institute for Clinical and Translational Science (NIH) [UL1 RR024979]

向作者/读者索取更多资源

Motivation: The Affymetrix Human Exon Junction Array is a newly designed high-density exon-sensitive microarray for global analysis of alternative splicing. Contrary to the Affymetrix exon 1.0 array, which only contains four probes per exon and no probes for exon-exon junctions, this new junction array averages eight probes per probeset targeting all exons and exon-exon junctions observed in the human mRNA/EST transcripts, representing a significant increase in the probe density for alternative splicing events. Here, we present MADS+, a computational pipeline to detect differential splicing events from the Affymetrix exon junction array data. For each alternative splicing event, MADS+ evaluates the signals of probes targeting competing transcript isoforms to identify exons or splice sites with different levels of transcript inclusion between two sample groups. MADS+ is used routinely in our analysis of Affymetrix exon junction arrays and has a high accuracy in detecting differential splicing events. For example, in a study of the novel epithelial-specific splicing regulator ESRP1, MADS+ detects hundreds of exons whose inclusion levels are dependent on ESRP1, with a RT-PCR validation rate of 88.5% (153 validated out of 173 tested).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据